Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Roche To Work On Reversing English Funding Rejection For SMA Drug
But Tecentriq Gets NICE Thumbs Up For NSCLC
Jun 04 2021
•
By
Neena Brizmohun
Roche needs to offer a price for Evrysdi that is cost-effective for the NHS • Source: Alamy
More from United Kingdom
More from Europe